Citadel Advisors
BTMD icon

Citadel Advisors’s Biote Corp BTMD Stock Holding History

Citadel Advisors’s Portfolio BTMD Stock Details BTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-84,351
Closed -$219K – 13040
2025
Q4 		$219K Buy
+84,351
New +$231K ﹤0.01% 10841
2025
Q3 		– Sell
-33,749
Closed -$136K – 12828
2025
Q2 		$136K Buy
33,749
+14,268
+73% +$52.6K ﹤0.01% 11054
2025
Q1 		$64.9K Buy
+19,481
New +$92.9K ﹤0.01% 12016
2024
Q4 		– Sell
-39,254
Closed -$219K – 14546
2024
Q3 		$219K Sell
39,254
-36,334
-48% -$242K ﹤0.01% 9965
2024
Q2 		$565K Buy
+75,588
New +$466K ﹤0.01% 7812
2023
Q3 		– Sell
-15,756
Closed -$107K – 14322
2023
Q2 		$107K Buy
+15,756
New +$93.5K ﹤0.01% 10842
2022
Q2 		– Sell
-100,764
Closed -$996K – 12931
2022
Q1 		$996K Sell
100,764
-296,121
-75% -$2.91M ﹤0.01% 7699
2021
Q4 		$3.9M Buy
396,885
+295,000
+290% +$2.88M ﹤0.01% 4800
2021
Q3 		$992K Buy
+101,885
New +$987K ﹤0.01% 8167

Other funds holding BTMD

3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
BP
Bandera Partners New York $221M AUM 10.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citadel Advisors's BTMD Position: Q1 2026 in Review

Citadel Advisors sold out of Biote Corp (BTMD) in Q1 2026, closing a stake of 84,351 shares — an estimated $219K sold.

Citadel Advisors first reported a position in BTMD in Q3 2021 and held it in 9 quarters. The position peaked at $3.9M in Q4 2021. 84 funds tracked by Wall St. Rank hold BTMD as of Q1 2026.

  • Citadel Advisors reported no remaining Biote Corp position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 84,351 Biote Corp shares in Q1 2026, an estimated $219K.
  • Citadel Advisors first reported a position in Biote Corp in Q3 2021 and held it in 9 quarters.
  • Citadel Advisors's Biote Corp position peaked at $3.9M in Q4 2021.
  • 84 funds tracked by Wall St. Rank held Biote Corp as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.